Your browser doesn't support javascript.
loading
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
Coilly, Audrey; Sebagh, Mylène; Fougerou-Leurent, Claire; Pageaux, Georges-Philippe; Leroy, Vincent; Radenne, Sylvie; Silvain, Christine; Lebray, Pascal; Houssel-Debry, Pauline; Cagnot, Carole; Rossignol, Emilie; Danjou, Hélène; Veislinger, Aurélie; Samuel, Didier; Duclos-Vallée, Jean-Charles; Dumortier, Jérôme.
Affiliation
  • Coilly A; AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire; Université Paris-Saclay, UMR-S 1193; Inserm Unité 1193; FHU Hepatinov, Villejuif 94800, France. Electronic address: audrey.coilly@aphp.fr.
  • Sebagh M; AP-HP Hôpital Bicêtre, Service d'Anatomie Pathologique, Kremlin-Bicêtre, France.
  • Fougerou-Leurent C; Rennes University Hospital, Unit of Clinical Pharmacology; INSERM Clinical Investigation Centre 1414, Rennes, France.
  • Pageaux GP; CHU Saint-Eloi, Département D'hépato-Gastroentérologie et de Transplantation Hépatique, Université Montpellier 1, Montpellier, France.
  • Leroy V; CHU de Grenoble, Pôle Digidune, Clinique Universitaire d'Hépato-Gastroentérologie; Unité INSERM /Université Grenoble Alpes U823, IAPC Institut Albert Bonniot, Grenoble, France.
  • Radenne S; Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service d'Hépato-gastroentérologie, Lyon, France.
  • Silvain C; Département d'Hépato-gastroentérologie, CHU de Poitiers, Pôle Biologie Santé, Poitiers EA 4331, France.
  • Lebray P; AP-HP, Departement d'hépatologie et de Gastroenterologie, Groupe Hospitalier Pitié-Salpétrière, Université Pierre et Marie Curie Paris 6, Paris, France.
  • Houssel-Debry P; CHU Rennes, Service des Maladies du Foie, Rennes, France.
  • Cagnot C; Unit for Basic and Clinical Research on Viral Hepatitis, ANRS (France Recherche Nord&sud Sida-hiv Hépatites), Paris, France.
  • Rossignol E; Rennes University Hospital, Unit of Clinical Pharmacology; INSERM Clinical Investigation Centre 1414, Rennes, France.
  • Danjou H; Rennes University Hospital, Unit of Clinical Pharmacology; INSERM Clinical Investigation Centre 1414, Rennes, France.
  • Veislinger A; Rennes University Hospital, Unit of Clinical Pharmacology; INSERM Clinical Investigation Centre 1414, Rennes, France.
  • Samuel D; AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire; Université Paris-Saclay, UMR-S 1193; Inserm Unité 1193; FHU Hepatinov, Villejuif 94800, France.
  • Duclos-Vallée JC; AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire; Université Paris-Saclay, UMR-S 1193; Inserm Unité 1193; FHU Hepatinov, Villejuif 94800, France.
  • Dumortier J; Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'Hépato-gastroentérologie, Université Claude Bernard Lyon 1, Pavillons D et L, 69437, Lyon Cedex 03, France. Electronic address: jerome.dumortier@chu-lyon.fr.
Clin Res Hepatol Gastroenterol ; 46(9): 102024, 2022 11.
Article in En | MEDLINE | ID: mdl-36122871
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangitis / Liver Transplantation / Hepatitis C / Hepatitis C, Chronic Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangitis / Liver Transplantation / Hepatitis C / Hepatitis C, Chronic Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article